YATES CLAYTON CLOPTON (Chief Scientific Officer) received a stock award from GENVOR INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/23/2025ACC: 0001903596-25-000319
DirectorOfficer10% Owner· Chief Scientific Officer
Since Aug 2023
+400K
Net shares
Net buyer
$100.0K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
400K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+400K
Price / share
$0.25
Trade value
$100K
% of position
New position
5/8/2025
0.00→400K
Total
Net shares
+400K
Net value
$100K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/8/2025 | A · Award | +400K | $0.25 | $100K | New position | 0.00 | 400K |
| Total | +400K | $100K | ||||||
Derivative Transactions0
No derivative transactions reported